February 15, 2019 | FIERCE-21: Phase 2 Study of Vofatamab (B-701), a Selective Inhibitor of FGFR3, as Salvage Therapy in Metastatic Urothelial Carcinoma. 2019 ASCO Genitourinary Cancers Symposium. Abstract #409

Click image to download full PDF

June 2018 | FIERCE-21 Phase 1b/2 Study of Docataxel + B-701 in Treatment Of Metastatic Urothelial Carcinoma

Click image to download full PDF